back to investments

Synerlab, the niche pharmaceutical manufacturing expert controlled by 21 Centrale Partners, raises €M 160 to finance its growth

Synerlab is pursuing its growth momentum and raises a €M 160 debt from ICG and Goldman Sachs.21 Centrale Partners took over Synerlab in December 2013, with the support of Ardian, to create a pan-European CDMO (Contract Development and Manufacturing Organization), leader on its market and a reference in terms of customer service and innovation

Synerlab is pursuing its growth momentum and raises a €M 160 debt from ICG and Goldman Sachs.21 Centrale Partners took over Synerlab in December 2013, with the support of Ardian, to create a pan-European CDMO (Contract Development and Manufacturing Organization), leader on its market and a reference in terms of customer service and innovation.Synerlab Group's sales have grown by 30% thanks to an optimized structuring, the improvement of its product range positioned on buoyant niche markets, an increase in its production capacity through organic growth and the opening of new markets through external growth.This new financing of €M 160 at attractive terms with ICG and Goldman Sachs, allows the group to refinance its current debt, finance its future investments and continue its external growth strategy, in particular with two strategic acquisitions abroad, which could be finalized in the coming months.Gérard Pluvinet, Chairman of 21 Centrale Partners declares: « This operation strengthens the growth project we are pursuing with Synerlab and its teams. The Group, which has undergone major transformations in the recent years, will be able to accelerate its European development, following a successful first acquisition in Spain at the end of 2015 »Pierre Banzet, CEO of Synerlab adds: «With 21 Centrale Partners and Ardian, for several years we have undertaken a new stage in our development both in France and internationally. The refinancing will provide us with additional means to pursue our ambitions ».

France highlights and news

Un aggiornamento sulle nostre attività recenti.